Portfolio Update

Finsbury Worldwide Pharm Tst PLC
05 July 2005



                                                                     5 July 2005


                    FINSBURY WORLDWIDE PHARMACEUTICAL TRUST PLC
                                   (the 'Company')

                          QUARTERLY STATEMENT OF INVESTMENTS


In compliance with the Listing Rules - Chapter 21 Investment Entities (I)(ii),
the Company discloses the following:


  • Investments valuing greater than 5% of the Company's gross assets comprise
    the following:


Company Name                                                        Value of Investment at      % of Total
                                                                         30 June 2005           Portfolio  Assets
                                                                         
Genentech Inc                                                             25,551,340               8.93
Pfizer Com                                                                23,084,326               8.07
Novartis                                                                  17,805,491               6.22
Altana AG                                                                 14,640,781               5.12
Amgen                                                                     14,335,407               5.01



  • The ten largest investments held by the Company comprise the following:


Company Name                                                         Value of Investment at      % of Total
                                                                         30 June 2005            Portfolio Assets
                                                                   

Genentech Inc                                                              25,551,340               8.93
Pfizer Com                                                                 23,084,326               8.07
Novartis                                                                   17,805,491               6.22
Altana AG                                                                  14,640,781               5.12
Amgen                                                                      14,335,407               5.01
Medimmune Inc                                                              14,012,553               4.90
Lilly (Eli) & Company                                                      13,053,753               4.56
Takeda Pharmaceutical                                                      12,078,384               4.22
Genzyme Corp General Division                                              11,830,999               4.14
Affymetrix Inc                                                             11,341,864               3.96


                                    - ENDS -

For further information please contact:

Tracey Lago, Company Secretary

Close Finsbury Asset Management Limited

Telephone: [phone]


                      This information is provided by RNS
            The company news service from the London Stock Exchange